A detailed history of Comerica Bank transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Comerica Bank holds 6,414 shares of IOVA stock, worth $70,746. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,414
Previous 6,402 0.19%
Holding current value
$70,746
Previous $94,000 45.74%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$7.78 - $14.19 $93 - $170
12 Added 0.19%
6,414 $51,000
Q1 2024

May 15, 2024

BUY
$7.59 - $17.47 $1,305 - $3,004
172 Added 2.76%
6,402 $94,000
Q4 2023

Feb 14, 2024

SELL
$3.3 - $8.89 $1,376 - $3,707
-417 Reduced 6.27%
6,230 $50,000
Q3 2023

Nov 21, 2023

BUY
$4.44 - $8.79 $29,512 - $58,427
6,647 New
6,647 $30,000
Q1 2021

Apr 28, 2021

SELL
$28.67 - $52.59 $131,595 - $241,388
-4,590 Closed
0 $0
Q4 2020

Jan 28, 2021

BUY
$28.04 - $50.26 $128,703 - $230,693
4,590 New
4,590 $212,000

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.74B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Comerica Bank Portfolio

Follow Comerica Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.